Japan Tissue Engineering Co., Ltd. (TYO:7774)
Japan · Delayed Price · Currency is JPY 723.00
-8.00 (-1.09%)
At close: Mar 6, 2026
Japan Tissue Engineering Market Cap
Japan Tissue Engineering has a market cap or net worth of 29.36 billion as of March 6, 2026. Its market cap has increased by 59.25% in one year.
Market Cap
29.36B
Enterprise Value
26.03B
Revenue
2.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
723.00
Market Cap Chart
Since December 21, 2007, Japan Tissue Engineering's market cap has increased from 5.99B to 29.36B, an increase of 389.97%. That is a compound annual growth rate of 9.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 29.36B | 16.24% |
| Dec 30, 2025 | 25.26B | 34.34% |
| Dec 30, 2024 | 18.80B | -8.50% |
| Dec 29, 2023 | 20.55B | 8.35% |
| Dec 30, 2022 | 18.96B | -17.49% |
| Dec 30, 2021 | 22.99B | -8.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cuorips | 56.45B |
| Healios K.K. | 54.27B |
| Renascience | 23.85B |
| AnGes | 21.76B |
| RaQualia Pharma | 21.75B |
| StemRIM | 17.43B |
| ReproCELL | 16.00B |
| Kubota Pharmaceutical Holdings | 15.12B |